A novel prognostic biomarker combining <i>TP53</i> loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy.

Oncol Lett · 2026 · PMC13184589 · PMID 42164467

Europe PMC DOI

hedged sentence

0.0480

closest p · 1.0× alpha

0.0480

boldest claim

The sentences

marginally significantP=0.048actually significant

However, marginally significant differences were observed in terms of smoking history (P=0.048) and tumor stage (P=0.049).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A novel prognostic biomarker combining &lt;i&gt;TP53&lt;/i&gt; loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy.

The sentences

A novel prognostic biomarker combining <i>TP53</i> loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy.